FSCN1 is differentially expressed in cancer cells, where it organizes actin filaments into pseudopodia and enhances ECM degradation by matrix metalloprotease (MMPs) and, therefore, contributes to the malignant phenotype and development and progression of tumors (220). Here, FSCN1 is linked to cancer.